Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
GLCCI1 encodes a protein of unknown function. Zusätzlich bieten wir Ihnen und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 60 products:
The GLCCI1 rs37973 variant is a risk factor for glucocorticoid resistance in Chinese patients with SAR (zeige SARDH Antikörper) who receive short-term intranasal corticosteroids treatment. one genotype of GLCCI1, rs37973, was significantly associated with the INCS response. The effective rate of the GG group was lower than those of the AA and AG groups (AA vs. GG: 73.7% vs. 51.6%, P=0.007; AG vs. GG: 78.8% vs. 51.6%, P=0.000).
A worsening of pulmonary function caused by GLCCI1 variants could be prevented due to recently used medications based on new action mechanisms.
The genetic variant rs37973 in GLCCI1 is associated with poorer clinical therapeutic response to inhaled glucocorticoids in a Chinese asthma population.
GLCCI1 variations may affect inhaled corticosteroid response by modulating GLCCI1 expression.
Carriers of the GLCCI1-C allele had lower levels of baseline rheumatoid arthritis disease activity, suggesting a role for the GLCCI1 gene in regulation of glucocorticoid sensitivity to endogenously produced cortisol.
Carriers of the rs41423247 GLCCI1 polymorphism had a higher probability of responding to glucocorticoids, whereas all other polymorphisms did not affect the likelihood of response to treatment of graft-versus-host disease patients.
GLCCI1 rs37972 T allele was not significantly associated with an increased risk of oral corticosteroid use.
GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.
Novel association was found between intraocular pressure and a common variant at 7p21 near to GLCCI1 and ICA1 (zeige ICA1 Antikörper).
GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma.
These findings suggest that Glcci1 is a new marker of a subpopulation of lateral ganglionic eminence ventricular zone progenitor cells in the Gsx2 (zeige GSX2 Antikörper) lineage.
Glcci1 promotes the normal development and maintenance of podocyte structure and function.
This gene encodes a protein of unknown function. Expression of this gene is induced by glucocorticoids and may be an early marker for glucocorticoid-induced apoptosis. Single nucleotide polymorphisms in this gene are associated with a decreased response to inhaled glucocorticoids in asthmatic patients.
glucocorticoid-induced transcript 1 protein
, glucocorticoid-induced gene 18 protein
, thymocyte/spermatocyte selection 1
, thymocyte/spermatocyte selection protein 1
, glucocorticoid induced transcript 1
, uncharacterized protein LOC296884